Background illustration for clinical trials search

Lung Cancer Clinical Trials

Browse 2,144 lung cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

for
Diabetes, Hypertension, High Cholesterol/Hyperlipidemia,
Location: Memphis TN
Sponsor: University of Tennessee

Sex: All

Age: 18+

Code: NCT06374277

Recruiting

A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change

for
Metastatic Cancer
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05010031

Phase 2, Recruiting

A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors

for
Solid Tumor, Adult, Advanced Solid Tumor, Advanced Cancer,
Location: Boston MA, New York NY, Houston TX, San Antonio TX,
Sponsor: Monopteros Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04859777

Phase 1, Recruiting

Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence

for
Solid Tumor
Location: Orange CA, Long Beach CA
Sponsor: Miller Children's & Women's Hospital Long Beach

Sex: All

Age: 1 - 31

Code: NCT02446431

Early Phase 1, Recruiting

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

for
Castration-Resistant Prostate Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04693377

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

for
Metastatic Castration Resistant Prostate Cancer (mCRPC),
Location: Myrtle Beach SC, Nashville TN, Omaha NE, Irving TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT03460977

Phase 1, Recruiting

Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT06562777

Recruiting

Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Patients With Solid Tumors

for
Metastatic Solid Tumor, Locally Advanced Solid Tumor
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT06358677

Phase 2, Recruiting

Positron Emission Tomography (PET) Imaging of Thrombosis

for
Atrial Fibrillation, COVID-19, Cancer, Thrombosis
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18 - 70+

Code: NCT03830320

Phase 1, Recruiting

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

for
Carcinomas (Including Squamous Cell and Adenocarcinoma),
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT00349830

Recruiting

Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers

for
NSCLC
Location: Boston MA, Hartford CT, Lebanon NH, New York NY,
Sponsor: Lung Cancer Mutation Consortium

Sex: All

Age: 0+

Code: NCT04712877

Recruiting

A New Psychotherapy Intervention for Older Cancer Patients

for
Cancer
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 70+

Code: NCT04452825

Recruiting

Safety of PUR001 Monotherapy in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Houston TX
Sponsor: Purinomia Biotech, Inc.

Sex: All

Age: 18+

Code: NCT05234853

Phase 1, Recruiting

DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic Solid Tumors
Location: New Haven CT, The Bronx NY, Baltimore MD, Miami FL,
Sponsor: DynamiCure Biotechnology

Sex: All

Age: 18+

Code: NCT05785754

Phase 1, Recruiting

Imaging Measures of Respiratory Health Registry

for
Respiratory Disease, Healthy
Location: Vancouver
Sponsor: University of British Columbia

Sex: All

Age: 0 - 70+

Code: NCT05102825

Recruiting

Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors

for
Neuroendocrine Cancer, Small Cell Lung Cancer,
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 18+

Code: NCT00178698

Phase 2, Recruiting

Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery

for
Oncologic Surgery, Cancer, Cancer Surgery, Hepatic Cancer,
Location: Pittsburgh PA
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Sex: All

Age: 18 - 70+

Code: NCT06731998

Recruiting

Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease

for
Non-Small Cell Lung Cancer
Location: Boston MA, Stuart FL, Birmingham AL, Nashville TN
Sponsor: Precision Therapeutics

Sex: All

Age: 18+

Code: NCT01450553

Recruiting

Feasibility of Hyivy Device Post-Radiation for Pelvic Malignancies

for
Vaginal Stenosis, Radiation Therapy, Cancer, Pelvic Pain,
Location: Kitchener
Sponsor: Hyivy Health Inc

Sex: Female

Age: 18+

Code: NCT05648253

Recruiting

A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

for
Malignant Neoplasm
Location: Fairfax VA, Houston TX, San Antonio TX
Sponsor: Tyligand Pharmaceuticals (Suzhou) Limited

Sex: All

Age: 18 - 70+

Code: NCT06385925

Phase 1, Phase 2, Recruiting

What is lung cancer?

Lung cancer starts when cells in the airways or lungs grow out of control. About 229,000 Americans will be diagnosed in 2026. There are two main types: non small cell lung cancer, about 85 percent of cases, and small cell lung cancer, which grows and spreads faster and is treated differently. Smoking causes most cases, but 10 to 20 percent happen in people who never smoked, from causes like radon, air pollution, or genetic changes. Most people are diagnosed around age 70.

Two things changed treatment. First, many lung cancers are driven by a single gene change, and pills that target that specific change can control the cancer for years, so tumors are now routinely tested for these changes before treatment starts. Second, immunotherapy works especially well in lung cancer, and some people with advanced disease are alive and well more than five years later. New targeted drugs kept getting approved through 2025, which is why lung cancer has more recruiting trials than any cancer except breast cancer.

Types of lung cancer clinical trials

Who can participate in lung cancer clinical trials?

What causes lung cancer?

Does vaping cause lung cancer?

The stages of lung cancer, and why they matter for trials

How to enroll in a lung cancer clinical trial